2 terminated, 2 unknown, 1 completed, 1 withdrawn. 5 Phase 2, 4 Phase 1, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Terminated 2, Unknown 2, Withdrawn 1 |
| Phase 1 | 4 | Unknown 2, Terminated 1, Withdrawn 1 |
| Early Phase 1 | 1 | Completed 1 |
Follow onapristone: new trials by email Literature Review of onapristone trials Research Report on onapristone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Rollover Protocol of Elacestrant, in Combination With Onapristone, for Patients With ER+, PR+, HER2- Advanced or Metastatic Breast Cancer Elacestrant, Onapristone - Breast Cancer | Phase 1 / Phase 2 | Withdrawn | Context Therapeutics Inc. | 2023-06-01 | 2025-04-22 | |
| Study of Elacestrant in Combination With Onapristone in Patients With Advanced or Metastatic Breast Cancer Elacestrant, Onapristone - Breast Cancer | Phase 1 / Phase 2 | Terminated | Context Therapeutics Inc. | 4 | 2022-12-02 | 2026-07-21 |
| Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study) Onapristone, Fulvestrant - ER-positive Breast Cancer, HER2-negative Breast Cancer | Phase 2 | Terminated | University of Wisconsin, Madison | 11 | 2021-10-05 | 2024-05-03 |
| Onapristone as Preoperative Treatment for Postmenopausal Women With Hormone Receptor + and HER2- Breast Cancer Onapristone - Breast Cancer | Early Phase 1 | Completed | SOLTI Breast Cancer Research Group | 10 | 2020-11-06 | 2022-04-01 |
| Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer onapristone, abiraterone - Prostate Cancer, Metastatic Prostate Cancer | Phase 1 / Phase 2 | Unknown | Arno Therapeutics | 75 | 2014-02-01 | 2015-06-24 |
| Phase 1-2 Study of Onapristone in Patients With Progesterone Receptor Expressing Cancers onapristone - Progesterone Receptor Positive Tumor: Max 1 Line of Prior Chemotherapy, no Prior Hormone Therapy | Phase 1 / Phase 2 | Unknown | Arno Therapeutics | 60 | 2014-01-01 | 2015-06-24 |
Breast Neoplasms (4) · Endometrial Neoplasms (1) · Genital Diseases, Male (1) · Genital Neoplasms, Male (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Neoplasms by Site (1) · Ovarian Neoplasms (1) · Prostatic Diseases (1) · Prostatic Neoplasms (1) · Urogenital Neoplasms (1)
Arno Therapeutics (2) · Context Therapeutics Inc. (2) · SOLTI Breast Cancer Research Group (1) · University of Wisconsin, Madison (1)
United States (3) · France (1) · Spain (1) · United Kingdom (1)
Kari B Wisinski, MD (1) · Paul H Cottu, MD (1) · Sailaja Kamaraju, MD, MS (1)
2019 (1)